CellWell record HH-226356
Characteristics of Copayment Offsets for Prescription Drugs in the United States.
Aditi P. Sen; So-Yeon Kang; Emaan S. Rashidi; Devoja Ganguli; G. Anderson; G. Alexander
JAMA Internal Medicine ยท 2021
In plain language
Copayment offsets covered 12.8% of prescriptions, with manufacturer offsets averaging $51 (87% of patient costs) and pharmacy-PBM offsets averaging $16 (39% of costs).
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-226356
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.